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An outbreak of inﬂ  uenza A pandemic (H1N1) 2009 oc-
curred among campers and staff at a summer camp attend-
ed by children with hematologic and oncologic conditions. 
The overall attack rate was 36% and was highest among 
children and adolescents (43%), persons with cancer (48%), 
and persons with sickle cell disease (82%).
S
ince it was ﬁ  rst identiﬁ  ed in April 2009 (1), the inﬂ  u-
enza A pandemic (H1N1) 2009 virus has sickened >1 
million persons in the United States (www.cdc.gov/h1n1-
ﬂ  u/surveillanceqa.htm). Because of the novelty of this vi-
rus, its transmissibility and severity are still under study.
We investigated an outbreak that occurred at a sum-
mer camp in northern rural Louisiana. Study approval was 
provided by the institutional review boards of Louisiana 
State University Health Sciences Center, Children’s Hos-
pital, and Tulane University Medical Center, New Orleans, 
Louisiana. 
The Study
The camp opened July 26, 2009 (day 1), with 101 
campers and 116 staff. Campers were children with he-
matologic or oncologic conditions and their nonaffected 
siblings. All participants were physically examined and 
questioned so that anyone with presence of or exposure to 
potentially communicable diseases could be excluded from 
attending camp. Campers (8–12/patrol) were grouped in 
age- and gender-speciﬁ  c patrols (B1–B4 and G1–G4) with 
assigned staff (4–5/patrol); they slept in bunkhouses and 
had common bathing facilities. All campers and staff dined 
together and shared various activities.
On day 2, fever developed in a healthy camper in pa-
trol G3 and promptly subsided. Fever also developed in a 
second camper (patrol B2) with sickle cell disease (SCD). 
This camper was seen at the local hospital, had a negative 
rapid inﬂ  uenza test (RIT) result, and was sent home. On 
day 3, fever and cough developed in 4 children (2 from 
B2); 1 was tested by RIT with a negative result. Evalua-
tion of the entire B2 patrol found no one else symptomatic. 
On day 4, fever developed in1 child with cancer (B2) and 
1 with SCD (G2 patrol); each had positive test results for 
inﬂ  uenza A virus.
The number of episodes of fever was considered ex-
cessive, and because additional campers reported having 
fever the camp was closed. At the time of dismissal, all 
campers and staff were provided masks and instructions 
about cough etiquette and handwashing; a dose of oselta-
mivir was also administered, and a prescription for oselta-
mivir was provided.
Ten days after the camp closed, all attendees were 
contacted (by email, telephone, and regular mail) to gath-
er information about their outcomes. Clinical signs and 
symptoms of interest were fever (measured or subjective) 
or chills; cough or sore throat; muscle pain; and nausea, 
vomiting, or diarrhea. On the basis of an adaptation of the 
deﬁ  nition by the Centers for Disease Control and Preven-
tion (www.cdc.gov/h1n1ﬂ  u/clinicians), persons with fever 
or chills and symptoms in >2 other categories were clas-
siﬁ  ed as having inﬂ  uenza-like illness (ILI); persons with 
fever alone (without an explanation) and symptoms in 1 
other category, or no documented fever but symptoms in 
>2 other categories, were classiﬁ  ed as having probable ILI 
(P-ILI). A case-patient was deﬁ  ned as a person in whom 
ILI or P-ILI developed within 10 days of closing of the 
camp.
Questionnaires were returned by 88 (76%) and 77 
(76%) of staff and campers, respectively. Mean age was 
22.5 (range 14–69) years for staff and 10.5 (range 5–15) 
years for campers. Of 88 staff, 56 reported no chronic 
medical condition; a few reported cancer in remission (n 
= 7), SCD (n = 3), or other conditions (n = 22: 9 asthma, 2 
inﬂ  ammatory bowel disease, 2 unspeciﬁ  ed, and 1 each with 
epilepsy, gall stones, chronic hepatitis C, immune throm-
bocytopenic purpura, Kartagener syndrome, mental retar-
dation, porphyria, stroke, and type 1 diabetes mellitus). Of 
77 campers, 45 (58%) reported no underlying illness, and 
a few reported cancer (n = 20: 12 leukemia, 2 lymphoma, 
4 solid organ tumor, 2 unspeciﬁ  ed; 2 were receiving main-
tenance therapy, the others had completed treatment), SCD 
(n = 8), or other (n = 4: 2 asthma, 1 immune thrombocy-
topenic purpura, and 1 cardiomyopathy).
Of 165 attendees who returned the questionnaire, 59 
(38.5%) reported symptoms: fever (40, 68%), cough (30, 
51%), sore throat (21, 36%), muscle pain (16, 27%), nau-
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nose (6, 10%), and headache (4, 7%). Abdominal pain, 
weakness, earache, conjunctivitis, and joint stiffness were 
rare. Pain crisis developed in 2 patients with SCD. Twenty-
ﬁ  ve patients met the deﬁ  nition of ILI, and 34 met the deﬁ  -
nition of P-ILI (Figure). Symptoms were more common 
among campers than staff (46.8% vs. 26.1%; p = 0.009), 
persons of younger age (Table 1), and persons with cancer 
or SCD (Table 2). Proportions were compared with 2-tailed 
χ2 or Fisher exact test by using Epi Info version 3.5 (www.
cdc.gov/Epiinfo).
Probably because of small numbers, no difference was 
evident in the attack rate between staff assigned and unas-
signed to a patrol, between boy and girl campers, between 
patrols, or between those who recalled or did not recall be-
ing in contact with a case-patient. Twenty-six case-patients 
sought medical attention, and 12 (2 staff and 10 campers) 
were hospitalized; 8 had SCD and 4 were in active cancer 
treatment; all were regular-ﬂ  oor admissions; none required 
oxygen support or other intensive care; mean length of stay 
was 4.25 (range 3–6) days; and all recovered uneventfully.
Twenty-ﬁ  ve persons (18 campers and 7 staff) were 
tested for inﬂ  uenza: 13 were tested at an outside facility, of 
whom 3 had positive results (method of testing unknown); 
12 were tested at Children’s Hospital by RIT (BinaxNOW; 
Invernass Medical, Waltham, MA, USA) and direct im-
munoﬂ   uorescence assay (D3 Ultra; Diagnostic Hybrids, 
Athens, OH, USA), and 5 (42%) had positive test results 
for inﬂ  uenza A virus. Of the 5 positive specimens obtained 
from patients, 4 were conﬁ  rmed as pandemic (H1N1) 2009 
virus by real-time reverse transcription–PCR.
Conclusions
Limited preliminary information is available about 
summer camp outbreaks of pandemic (H1N1) 2009 (2). 
The closest scenarios (school outbreaks) reported attack 
rates of 3%–33% in the United States (3–5) and 2%–31% 
in the United Kingdom (6,7). Differences between studies 
and groups probably reﬂ  ect different levels of exposure and 
surveillance deﬁ  nitions. In the outbreak reported here, the 
overall attack rate was 36%; infection was more common 
among campers (47%), children and adolescents (43%), 
those with cancer (48%), and those with SCD (82%). 
Because of their underlying condition, the threshold for 
evaluation and intervention is lower for children with he-
matologic or oncologic processes, which might account 
for some increased reporting of symptoms, hospitalization, 
and extended stay.
Children with SCD were disproportionately affected; 
82% of them reported symptoms, and 89% of those symp-
tomatic were hospitalized because of fever or pain crisis. 
For seasonal inﬂ  uenza, the hospitalization rate is 56× high-
er for children with SCD than those without SCD (8); the 
same trend seems true for pandemic (H1N1) 2009 infection. 
Among those with no underlying condition, the inﬂ  uenza 
attack rate was lower (28%), few (11%) persons sought 
medical attention, and none were hospitalized. For persons 
with no underlying condition, the reported symptoms sug-
gest an illness no more severe than seasonal inﬂ  uenza.
A few limitations should be recognized. First, 25% of 
attendees did not return the questionnaire. Second, we used 
a clinical deﬁ  nition of ILI; however, although the limitations 
of the deﬁ  nition are well recognized, it is a well-accepted 
tool for outbreak investigation. Third, data are based on re-
call and report by participants. Fourth, only a few persons 
were tested to determine the causative agent. However, of 
the 12 patients we tested at Children’s Hospital, 5 (42%) 
had inﬂ  uenza A virus and 4 were conﬁ  rmed as having pan-
demic (H1N1) 2009 virus infection. This level of positivity 
is in accordance with sensitivity reported for available tests 
(9,10) and suggests that most, if not all, cases of ILI identi-
ﬁ  ed were caused by pandemic (H1N1) 2009 virus.
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Figure. Outbreak curve of inﬂ  uenza-like illness (ILI) and probable 
ILI (P-ILI) cases during the 4 days of summer camp for children with 
hematologic and oncologic conditions (1–4) and the 10 days (5–14) 
after closing the camp, Louisiana, USA, 2009. 
Table 1. Attack rates of influenza-illness according to age and 
underlying medical condition at summer camp for children with 
hematologic and oncologic conditions, Louisiana, USA, 2009* 
Age group, y 
Underlying condition, no. positive/no. tested (%) 
No† Yes‡ All§ 
5–15  19/54 (35.2)  18/33 (54.5)  37/87 (42.5) 
16–30  10/41 (24.4)  11/28 (39.3)  21/69 (30.4) 
31–69  0/6 (0)  1/3 (33.3)  1/9 (11.1) 
Total 29/101 (28.7)  30/64 (46.9)  59/165 (35.8) 
*By F
2 test for trend for increasing age groups within each category. 
†p = 0.049. 
‡p = 0.255. 
§p = 0.027. Pandemic (H1N1) 2009 Outbreak at Camp for Children 
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Table 2. Risk for influenza and hospitalization according to category of underlying condition at summer camp for children with 
hematologic and oncologic conditions, Louisiana, USA, 2009*  
Underlying condition 
Risk for influenza symptoms  Risk for hospitalization, if symptomatic 
Staff Campers All Staff Campers  All
None  10/56 (17.9)  19/45 (42.2)  29/101 (28.7)  0/10 (0)  0/19 (0)  0/29 (0) 
Other than cancer or sickle cell 
disease
7/22 (31.8)  1/4 (25.0)  8/26 (30.8)  0/7 (0)  0/1 (0)  0/8 (0) 
Cancer  4/7 (57.1)† 9/20  (45.0)  13/27 (48.1)† 0/4  (0)  4/9 (44.4)‡ 4/13 (30.8)‡
Sickle cell disease  2/3 (66.6)† 7/8 (87.5)† 9/11 (81.8)‡ 2/2 (100.0)† 6/7 (85.7)§ 8/9 (88.9)§
Total 23/88 (26.1)  36/77 (46.8)  59/165 (35.8)  2/23 (8.7)  10/36 (27.8)  12/59 (20.3) 
*Values given as no. in category/total no. with condition (%). Boldface indicates significance. Data were analyzed by using 2-tailed Fisher exact test for 
each category compared with persons with no underlying condition. 
†p = 0.01–0.05. 
‡p = 0.0001–0.01. 
§p<0.0001. 
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